POLYSORBATE 80
Unresolved Excipient
Suggest One
No specific molecular structure known for this excipient.
- CAS
- 9005656
- UNII
- 6OZP39ZG8H
- SYNONYMS
-
- ZINC ID(s)
-
- Availability
- Present in 0 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Analogs cannot be located as there is no structure provided for this compound. Try a
search by name.
Functions of Polysorbate 80
| Af - Antifoaming (or defoaming) agent |
| Emul - Emulsifier |
| Misc - Miscellaneous |
| Sda - Solubilizing & dispersing agent |
Regulatory Status of Polysorbate 80
| Reg - Food additives for which a petition has been filed and a regulation issued. |
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Auricular (Otic) | Solution | 0.2% |
| Auricular (Otic) | Suspension | 5% |
| Im - Iv | Injection | |
| Inhalation | Suspension, For Inhalation | 0.02% |
| Intra-Articular | Injectable | 0.04% |
| Intra-Articular | Injection | 0.4% |
| Intra-Articular | Injection, Sustained Action | |
| Intrabursal | Injection | 0.04% |
| Intradermal | Injection | |
| Intradermal | Injection, Sustained Action | |
| Intralesional | Injectable | 0.04% |
| Intralesional | Injection | 0.2% |
| Intralesional | Injection, Sustained Action | |
| Intralesional | Suspension, Injection | 0.19% |
| Intramuscular | Injectable | 0.1% |
| Intramuscular | Injection | 12% |
| Intramuscular | Injection | 1.5MG |
| Intramuscular | Injection, Microspheres | 0.1% |
| Intramuscular | Injection, Sustained Action | |
| Intramuscular | Powder, For Injection Solution | |
| Intramuscular | Powder, For Injection Solution, Lyophilized | 0.2% |
| Intramuscular | Solution, Injection | 5% |
| Intramuscular | Suspension | 0.02% |
| Intramuscular | Suspension, Injection | 0.24% |
| Intrasynovial | Injection | 0.2% |
| Intrasynovial | Injection, Sustained Action | |
| Intrasynovial | Suspension, Injection | 0.19% |
| Intravenous | Infusion | |
| Intravenous | Injectable | 63%W/W |
| Intravenous | Injection | 10%W/V |
| Intravenous | Injection, Suspension | 2.5% |
| Intravenous | Powder, For Injection Solution, Lyophilized | 12% |
| Intravenous | Solution, Injection | 52% |
| Intravitreal | Suspension, Injection | 0.02% |
| Iv(Infusion) | Injectable | 26% |
| Iv(Infusion) | Injection | 8% |
| Iv(Infusion) | Powder, For Injection Solution | 5.3% |
| Iv(Infusion) | Powder, For Injection Solution, Lyophilized | 12.5% |
| Iv(Infusion) | Solution, Concentrate | 96.3%W/W |
| Nasal | Spray | 0.01% |
| Nasal | Spray, Metered | 10% |
| Ophthalmic | Drops | 0.1% |
| Ophthalmic | Emulsion | 4% |
| Ophthalmic | Solution | 0.2% |
| Ophthalmic | Solution, Drops | 1% |
| Ophthalmic | Solution, Gel Forming, Extended Release | 0.05% |
| Ophthalmic | Suspension | 0.1% |
| Ophthalmic | Suspension, Drops | 0.1% |
| Oral | Capsule | 418.37MG |
| Oral | Capsule, Coated Pellets | 0.05MG |
| Oral | Capsule, Delayed Action | 1.66MG |
| Oral | Capsule, Enteric Coated Pellets | 2MG |
| Oral | Capsule, Extended Release | 0.53MG |
| Oral | Capsule, Hard Gelatin | |
| Oral | Capsule, Soft Gelatin | 1MG |
| Oral | Capsule, Soft Gelatin Liquid-Filled | 6MG |
| Oral | Capsule, Sustained Action | 2.6MG |
| Oral | Concentrate | 0.1% |
| Oral | Drops | 0.2% |
| Oral | Granule | 20MG |
| Oral | Granule, For Oral Suspension | 5MG |
| Oral | Liquid | |
| Oral | Pellet | 1.1MG |
| Oral | Powder, For Oral Suspension | 0.1% |
| Oral | Powder, For Solution | |
| Oral | Powder, For Suspension | 0.1% |
| Oral | Solution | 12.6% |
| Oral | Solution, Elixir | 0.02% |
| Oral | Suspension | 2.5% |
| Oral | Suspension, Drops | 0.3% |
| Oral | Suspension, For Inhalation | 0.02% |
| Oral | Suspension, Liquid | 0.1% |
| Oral | Suspension, Sustained Action | 5MG |
| Oral | Suspension, Syrup, Sustained Action | 0.06% |
| Oral | Tablet | 21.25MG |
| Oral | Tablet (Immed./comp. Release), Coated | 0.5MG |
| Oral | Tablet (Immed./comp. Release), Film Coated | 24MG |
| Oral | Tablet, Coated | 2.2MG |
| Oral | Tablet, Delayed Action | 0.52MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 0.17MG |
| Oral | Tablet, Extended Release | 0.42MG |
| Oral | Tablet, Film Coated | 14.8MG |
| Oral | Tablet, Film Coated, Extended Release | 3.38MG |
| Oral | Tablet, Orally Disintegrating, Delayed Release | 2.25MG |
| Oral | Tablet, Sustained Action | 0.12MG |
| Oral | Tablet, Sustained Action, Coated | 8MG |
| Oral | Tablet, Sustained Action, Film Coated | 0.2MG |
| Oral-28 | Tablet | 0.9MG |
| Rectal | Enema | 0.35% |
| Rectal | Liquid | |
| Rectal | Powder, For Solution | |
| Rectal | Solution | 0.75% |
| Rectal | Suppository | 72.15MG |
| Soft Tissue | Injectable | 0.04% |
| Soft Tissue | Injection | 0.2% |
| Soft Tissue | Injection, Sustained Action | |
| Soft Tissue | Suspension, Injection | 0.19% |
| Subcutaneous | Injection | |
| Subcutaneous | Suspension, Injection | 0.46% |
| Sublingual | Tablet | 0.08MG |
| Topical | Cream, Augmented | 15%W/W |
| Topical | Cream, Emulsion, Sustained Release | 5%W/W |
| Topical | Drops | |
| Topical | Emulsion | 2.5% |
| Topical | Emulsion, Cream | 4.5% |
| Topical | Gel | 8.5% |
| Topical | Lotion | 2.5% |
| Topical | Ointment | 0.1% |
| Topical | Patch, Controlled Release | |
| Vaginal | Emulsion, Cream | 0.5% |
| Vaginal | Suppository | 28MG |